Speaker: Dr. Mattias Björnmalm, Faculty of Engineering, Department of Materials, Imperial College London
Date: June 19, 2019
Time: 2:30 p.m.
Location: Lecture Hall of School of Chemistry and Chemical Engineering, Central Campus
Sponsor: the School of Chemistry and Chemical Engineering
The interface of bio–nano science and cancer medicine is an area experiencing much progress but also beset with controversy. Core concepts of the field— e.g., the enhanced permeability and retention (EPR) effect, tumor targeting and accumulation, and even the purpose of “nano” in cancer medicine—are hotly debated. In this talk we will (i) revisit how cancer is commonly treated in the clinic and how this relates to nanomedicine; (ii) examine the ongoing debate on the relevance of the EPR effect and tumor targeting; and (iii) highlight ways to improve the next-generation of nanomedicines; While discussing these challenges, and emerging opportunities, we will explore new directions for cancer nanomedicine.
Dr. Mattias Björnmalm is a Marie Sklodowska-Curie Fellow in the Department of Materials and the Department of Bioengineering at Imperial College London. He is based in Prof Molly Stevens’ lab, where he leads the EU-funded project qBionano.org focused on exploring biological interactions of nanomaterials. Prior to joining Imperial College London, he obtained his PhD in Chemical and Biomolecular Engineering from the University of Melbourne in Australia, where he worked with Prof Frank Caruso. He started his career in Sweden, where he obtained a BSc and MSc in biomedical engineering and nanoscience. He has over 40 publications, and the full list can be accessed via http://qBionano.org.
For more information, please visit:
Edited by Sun Yangyang